Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients...

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Systemic therapies for advanced hepatocellular carcinoma (HCC) have limited efficacy.
• Identifying novel immunotherapy targets is crucial for improving HCC treatment outcomes.
• Natural Killer (NK) cells play a key role in anti-tumor immunity and response to therapies.

Purpose of the Study:

• To investigate the landscape of NK cell phenotypes in HCC patients.
• To identify potential NK cell-based immunotherapy targets for HCC.

Main Methods:

• Single cell mass cytometry was used to analyze 32 surface markers on CD56^dim and CD56^bright NK cells.
• Peripheral NK cells from HCC patients and healthy volunteers were compared.
• NK cells from peripheral and intrahepatic tissues (cancerous and noncancerous) of HCC patients were analyzed.

Main Results:

• In HCC patients, peripheral CD160⁺CD56^dim NK cells expressing Siglec-7, NKp46, and NKp30 were decreased.
• Peripheral CD49a⁺CD56^dim NK cells expressing Siglec-10 were increased in HCC patients.
• CD160 and CD49a were identified as signature molecules on CD56^dim NK cells, correlating with other NK markers.
• CD49a⁺ CX3CR1⁺ Siglec-10⁺ NK cells were found to accumulate within HCC tissues.

Conclusions:

• CD160 and CD49a are potential signature molecules for CD56^dim NK cells in HCC.
• Accumulation of CD49a⁺ CX3CR1⁺ Siglec-10⁺ NK cells in HCC tissues warrants further investigation.
• CD160, CD49a, CX3CR1, and Siglec-10 on CD56^dim NK cells represent promising targets for HCC immunotherapy.